rTMS Approved by NICE for Depression | Smart TMS London

The National Institute for Health and Care Excellence (NICE) in the UK has recently granted approval for repetitive Transcranial Magnetic Stimulation (rTMS) as a recognized and validated method for treating depression. This endorsement highlights rTMS as both an effective and safe therapeutic option for individuals suffering from depression across the UK. By acknowledging the efficacy and safety of rTMS, NICE has paved the way for broader acceptance and integration of this innovative treatment within the healthcare system, offering new hope and possibilities for patients seeking relief from depressive symptoms.

The guidelines provided by the National Institute for Health and Care Excellence (NICE) do not delineate a specific type of repetitive Transcranial Magnetic Stimulation (rTMS) treatment, thereby allowing for the utilization of both conventional rTMS and the more rapid theta burst stimulation. This flexibility in treatment options underscores the versatility and adaptability of rTMS in addressing depression, catering to the unique needs of each patient.

Consequently, private medical insurers are now faced with the imperative task of evaluating and potentially incorporating this innovative and effective treatment into their coverage policies. By doing so, they can ensure that their clients have access to cutting-edge mental health care solutions, which are not only safe and effective but also align with the latest advancements in medical technology.

Find TMS treatment with Smart TMS

Repetitive Transcranial Magnetic Stimulation treatment for depression is now available as an outpatient procedure performed in the treatment rooms at Smart TMS Clinics, Knightsbridge, London and further locations across the UK.

For any queries or to book an appointment, please contact us: